Predictors of Attrition from a National Sample of Methadone Maintenance Patients

REFERENCES

• Dole V, Nyswander ME, Warner A. Successful treatment of 750 criminal addicts. JAMA 1968; 206:2708–2711.
   PubMed Web of Science ®Google Scholar
• Simpson DD, Savage LJ, Lloyd MR. Follow-up evaluation of treatment abuse during 1969 to 1972. Arch Gen Psychiatry 1979; 36:772–780.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199–213.
   PubMed Web of Science ®Google Scholar
• Marsch, L. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998; 93:515–532.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2001; 62:255–264.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski CF, Booth RE. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users 2001. J Acquir Immune Defic Syndr 26:483–489.
   Google Scholar
• Simpson DD, Joe GW, Bracy SA. Six-year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry 1982; 39:1318–1323.
   PubMed Web of Science ®Google Scholar
• Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance. J Health Soc Behav 1998; 29:214–226.
   Google Scholar
• Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV Risk, and illicit drug use during treatment: Methadone dose and visit frequency. Am J Pub Health 1998; 88:34–39.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic evaluation Instrument for substance abuse patients: The addiction severity index. J Nerv Ment Dis 1980; 168:26–33.
   PubMed Web of Science ®Google Scholar
• Magura S, Nwakeze PC, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93:51–60.
   PubMed Web of Science ®Google Scholar
• Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 1996; 91:1197–1209.
   PubMed Web of Science ®Google Scholar
• Rothbard A, Alterman A, Rutherford M. Liu F, Zelinski S, McKay J. Revisiting the effectiveness of methadone treatment on crime reductions in the 1990s. J Sub Abuse Treat 1999; 16:329–335.
   PubMed Web of Science ®Google Scholar
• Keen J, Rowse G, Mathers N, Campbell M, Seivewright N. Can methadone maintenance for heroin-dependent patients retained in general practice reduce criminal conviction rates and time spent in prison? Br J Gen Pract 2000; 50:48–49.
   PubMed Web of Science ®Google Scholar
• Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Records 1998; 113:107–115.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Cavanaugh ER, Flynn PM, Anderson J, Etheridge M. Overview of 1-year follow-up outcomes in the Drug Abuse treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11:261–278.
   Web of Science ®Google Scholar
• Simpson DD, Joe GW, Brown SS. Treatment retention and follow-up outcomes in the Drug Abuse Outcome Treatment Study (DATOS). Psychol Addict Behav 1997; 11:294–307.
   Web of Science ®Google Scholar
• MacGowan RJ, Swanson NM, Brackbill RM, Rugg DL, Barker T, Molde S. Retention in methadone maintenance treatment programs, Connecticut and Massachusetts, 1990–1993. J Psychoactive Drugs 1996; 28:259–265.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M, Ali R, Cooke R, Ritter, Lynskey M. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2005; 28:255–263.
   PubMed Web of Science ®Google Scholar
• Schiff M, Levit S, Moreno RC. Retention and illicit drug use among methadone patients in Israel: a gender comparison. Addict Behav 2007; 32(10):2108–2119.
   Google Scholar
• Deck D, Carlson MJ. Retention in Publicly Funded Methadone Maintenance Treatment in Two Western States. J Behav Health Serv Res 2005; 32:43–60.
   PubMed Web of Science ®Google Scholar
• Anderson JF, Warren LD. Client retention in the British Columbia Methadone Program, 1996–1999. Can J Public Health 2004; 95:104–109.
   PubMed Web of Science ®Google Scholar
• Strike CJ, Gnam W, Urbanoski K, Fischer B, Marsh DC, Millson M. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addict Behav 2005; 30:1025–1028.
   PubMed Web of Science ®Google Scholar
• Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res 2000; 24:1525–1533.
   PubMed Web of Science ®Google Scholar
• Sorensen JL, Gibson D, Bernal G, Deitch D. Methadone applicant dropouts: impact of requiring involvement of friends or family treatment. Int J Addictions 1985; 20:1273–1280.
   PubMed Web of Science ®Google Scholar
• Joe GW, Simpson DD, Hubbard RL. Treatment predictors of tenure in methadone maintenance. J Subst Abuse 1991; 3:73–84.
   PubMedGoogle Scholar
• Steer RA. Psychosocial correlates of retention in methadone maintenance. Int J Addictions 1980; 15:1003–1009.
   PubMed Web of Science ®Google Scholar
• Favrat B, Rao S, O'Connor PG, Schottenfeld. A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics. J Subst Abuse 2002; 23:233–244.
   Google Scholar
• Gaughwin M, Solomon P, Ali R. Correlates of retention on the South Australian Methadone Program 1981–1991. Aust N Z J Public Health 1998; 22:771–776.
   PubMed Web of Science ®Google Scholar
• Maddux JF, Prihoda TJ, Vogtsberger KN. The relationship of methadone dose and other variables to outcomes of methadone maintenance. Am J Addictions 1997; 6:246–255.
   PubMed Web of Science ®Google Scholar
• Caplehorn JR, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Aust 1991; 154:195–199.
   PubMed Web of Science ®Google Scholar
• Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28:321–329.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Rutherford MJ, Alterman AI, McKay JR, Snider EC. Personality disorders and treatment outcome in methadone maintenance patients. J Nerv Ment Disease 1996; 184:234–239.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman A, Rutherford MJ, McKay JR, Mulvaney FD. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001; 61:271–280.
   PubMed Web of Science ®Google Scholar
• Maremmani I, Zolesi O, Aglietti., Marini G, Tagliamonte A, Shinderman M, Maxwell S. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis 2000; 19:29–41.
   PubMed Web of Science ®Google Scholar
• Milby JB, Sims MK, Khuder S, Schumacher JE, Huggins N. Psychiatric comorbidity: Prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse 1996; 22:95–107.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Anderson J. Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003; 25:125–134.
   PubMed Web of Science ®Google Scholar
• Charlson M, Pompie P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373–383.
   PubMedGoogle Scholar
• Curran GM, Stecker T, Han X, Booth BM. Individual and program predictors of attrition from VA substance use treatment. J Behav Health Serv Res 2009; 36:25–34.
   PubMed Web of Science ®Google Scholar
• Veterans Information Resource Center. (VIReC). Available at http://www.virec.research.va.gov/References/DataIssuesBrief/November2009/DIB-0911er.pdf
   Google Scholar
• Villafranca SW, McKellar JD, Trafton JA, Humphreys K. Predictors of retention in methadone programs: A signal detection analysis. Drug Alcohol Depend 2006; 83:218–224.
   PubMed Web of Science ®Google Scholar